Abstract
Background and Aims: Clonal hematopoiesis of indeterminate potential (CHIP) is an age-associated expansion of blood cells that carry specific somatic mutations. CHIP mutations double the risk of CAD and are associated with worse overall survival. Our research aims to understand how CHIP mutations change the myeloid cell biology and contribute to atherosclerosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
